Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier García Del Pozo

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
European Journal of Human Genetics : EJHG|November 29, 2012
Spanish regulatory approach for biobankingJavier Arias-Diaz, María C Martín-Arribas, Javier García del Pozo, et al.
Medicina Clinica|June 9, 2006
[Quality of observational post-authorization studies registered in Spain before their regulation]Beatriz Pérez Zafrilla, Javier García del Pozo, Antonio Aguilar Ros, et al.
Revista Espanola De Cardiologia|April 2, 2004
[Use of antihypertensive drugs in Spain (1995-2001)]Javier García del Pozo, Eduardo Ramos Sevillano, Francisco J de Abajo, et al.
Pharmacoepidemiology and Drug Safety|August 17, 2010
Trends in the consumption of antidepressants in Castilla y León (Spain). Association between suicide rates and antidepressant drug consumptionLuis H Martín Arias, Carlos Treceño Lobato, Sara Ortega, et al.
Parkinsonism & Related Disorders|May 29, 2007
A pharmacoepidemiological study of the consumption of antiparkinson drugs in the Basque Autonomous Community (Spain) (1992-2004)Eider Abasolo Osinaga, Luis Carlos Abecia Inchaurregui, Itziar Etxeandia Ikobaltzeta, et al.
Medicina Clinica|June 14, 2002
[Hormonal replacement therapy in Spain]Mikhail Benet Rodríguez, Alfonso Carvajal García-Pando, Javier García Del Pozo, et al.
European Journal of Clinical Pharmacology|June 29, 2004
Gastroprotection during the administration of non-steroidal anti-inflammatory drugs. A drug-utilization studyAlfonso Carvajal, Luis H Martín Arias, Eva Vega, et al.
The Journal of Clinical Psychiatry|March 5, 2002
Hepatotoxicity associated with the new antidepressantsAlfonso Carvajal García-Pando, Javier García del Pozo, Ana Sánchez Sánchez, et al.
Revista Espanola De Salud Publica|August 6, 2004
[The use of anxiolytic and hypnotic drugs in Spain (1995-2002)]Javier García del Pozo, Francisco J de Abajo Iglesias, Alfonso Carvajal García-Pando, et al.
Revista Espanola De Salud Publica|February 18, 2004
[Evolution of antipsychotic drug consumption in the autonomous community of Castile and Leon, Spain (1990-2001)]Javier García del Pozo, Laura Isusi Lomas, Alfonso Carvajal García-Pando, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
European Journal of Human Genetics : EJHG|November 29, 2012
Spanish regulatory approach for biobankingJavier Arias-Diaz, María C Martín-Arribas, Javier García del Pozo, et al.
Medicina Clinica|June 9, 2006
[Quality of observational post-authorization studies registered in Spain before their regulation]Beatriz Pérez Zafrilla, Javier García del Pozo, Antonio Aguilar Ros, et al.
Revista Espanola De Cardiologia|April 2, 2004
[Use of antihypertensive drugs in Spain (1995-2001)]Javier García del Pozo, Eduardo Ramos Sevillano, Francisco J de Abajo, et al.
Pharmacoepidemiology and Drug Safety|August 17, 2010
Trends in the consumption of antidepressants in Castilla y León (Spain). Association between suicide rates and antidepressant drug consumptionLuis H Martín Arias, Carlos Treceño Lobato, Sara Ortega, et al.
Parkinsonism & Related Disorders|May 29, 2007
A pharmacoepidemiological study of the consumption of antiparkinson drugs in the Basque Autonomous Community (Spain) (1992-2004)Eider Abasolo Osinaga, Luis Carlos Abecia Inchaurregui, Itziar Etxeandia Ikobaltzeta, et al.
Medicina Clinica|June 14, 2002
[Hormonal replacement therapy in Spain]Mikhail Benet Rodríguez, Alfonso Carvajal García-Pando, Javier García Del Pozo, et al.
European Journal of Clinical Pharmacology|June 29, 2004
Gastroprotection during the administration of non-steroidal anti-inflammatory drugs. A drug-utilization studyAlfonso Carvajal, Luis H Martín Arias, Eva Vega, et al.
The Journal of Clinical Psychiatry|March 5, 2002
Hepatotoxicity associated with the new antidepressantsAlfonso Carvajal García-Pando, Javier García del Pozo, Ana Sánchez Sánchez, et al.
Revista Espanola De Salud Publica|August 6, 2004
[The use of anxiolytic and hypnotic drugs in Spain (1995-2002)]Javier García del Pozo, Francisco J de Abajo Iglesias, Alfonso Carvajal García-Pando, et al.
Revista Espanola De Salud Publica|February 18, 2004
[Evolution of antipsychotic drug consumption in the autonomous community of Castile and Leon, Spain (1990-2001)]Javier García del Pozo, Laura Isusi Lomas, Alfonso Carvajal García-Pando, et al.
Pageof 2